A detailed history of Hikari Power LTD transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Hikari Power LTD holds 85,585 shares of AVXL stock, worth $352,610. This represents 0.04% of its overall portfolio holdings.

Number of Shares
85,585
Previous 85,585 -0.0%
Holding current value
$352,610
Previous $797,000 45.29%
% of portfolio
0.04%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 08, 2020

SELL
$3.8 - $5.0 $53,173 - $69,965
-13,993 Reduced 14.05%
85,585 $389,000
Q1 2020

Apr 23, 2020

SELL
$2.38 - $5.81 $784,500 - $1.92 Million
-329,622 Reduced 76.8%
99,578 $314,000
Q4 2019

Feb 04, 2020

SELL
$2.31 - $3.14 $89,882 - $122,177
-38,910 Reduced 8.31%
429,200 $1.11 Million
Q3 2019

Oct 31, 2019

BUY
$2.22 - $3.9 $652,746 - $1.15 Million
294,030 Added 168.91%
468,110 $1.48 Million
Q1 2019

Apr 26, 2019

BUY
$1.68 - $3.42 $43,680 - $88,920
26,000 Added 17.56%
174,080 $531,000
Q4 2018

Jan 29, 2019

BUY
$1.25 - $2.75 $185,100 - $407,220
148,080 New
148,080 $231,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $321M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Hikari Power LTD Portfolio

Follow Hikari Power LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hikari Power LTD, based on Form 13F filings with the SEC.

News

Stay updated on Hikari Power LTD with notifications on news.